Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paracervical bupivacaine for postoperative recovery after total laparoscopic hysterectomy
ACTRN12621000584831Phase 2Recruiting
- Sponsor
- St John of God Subiaco Hospital
- Start
- Sep 2021
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of bupivacaine and epinephrine in postoperative pain, sponsored by St John of God Subiaco Hospital. Primary endpoint: Quality of recovery at 24-36 hours. Started Sep 2021; status: recruiting.
02
Drugs
bupivacaineepinephrine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ACTRN12621000584831.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12621000584831.